Global Chimeric Antigen Receptor T Cell Therapy Market 2023 by Company, Regions, Type and Application, Forecast to 2029

Page: 112

Published Date: 06 Feb 2023

Category: Medical Care

PDF Download

Get FREE Sample

Customize Request

Description
Table of Contents
Table of Figures
Research Methodology
Related Reports
Product Tags

Description

According to our (Global Info Research) latest study, the global Chimeric Antigen Receptor T Cell Therapy market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

This report is a detailed and comprehensive analysis for global Chimeric Antigen Receptor T Cell Therapy market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.

Key Features:
Global Chimeric Antigen Receptor T Cell Therapy market size and forecasts, in consumption value ($ Million), 2018-2029
Global Chimeric Antigen Receptor T Cell Therapy market size and forecasts by region and country, in consumption value ($ Million), 2018-2029
Global Chimeric Antigen Receptor T Cell Therapy market size and forecasts, by Type and by Application, in consumption value ($ Million), 2018-2029
Global Chimeric Antigen Receptor T Cell Therapy market shares of main players, in revenue ($ Million), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Chimeric Antigen Receptor T Cell Therapy
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Chimeric Antigen Receptor T Cell Therapy market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Amgen, Bellicum Pharmaceuticals, Bluebird Bio, Caribou Biosciences and Celgene Corporation, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

Market segmentation
Chimeric Antigen Receptor T Cell Therapy market is split by Type and by Application. For the period 2018-2029, the growth among segments provide accurate calculations and forecasts for consumption value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type
    Allogeneic
    Autologous

Market segment by Application
    Hospitals
    Universities and Colleges
    Others

Market segment by players, this report covers
    Amgen
    Bellicum Pharmaceuticals
    Bluebird Bio
    Caribou Biosciences
    Celgene Corporation
    Cellectis
    Celyad Oncology
    Gilead Sciences
    Intellia Therapeutics
    Johnson & Johnson
    Legend Biotech
    Merck
    Noile-Immune Biotech
    Novartis
    Pfizer
    Sangamo Therapeutics
    Servier Laboratories

Market segment by regions, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
    South America (Brazil, Argentina and Rest of South America)
    Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Chimeric Antigen Receptor T Cell Therapy product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Chimeric Antigen Receptor T Cell Therapy, with revenue, gross margin and global market share of Chimeric Antigen Receptor T Cell Therapy from 2018 to 2023.
Chapter 3, the Chimeric Antigen Receptor T Cell Therapy competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and Chimeric Antigen Receptor T Cell Therapy market forecast, by regions, type and application, with consumption value, from 2024 to 2029.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War
Chapter 12, the key raw materials and key suppliers, and industry chain of Chimeric Antigen Receptor T Cell Therapy.
Chapter 13, to describe Chimeric Antigen Receptor T Cell Therapy research findings and conclusion.

Table of Contents

1 Market Overview
    1.1 Product Overview and Scope of Chimeric Antigen Receptor T Cell Therapy
    1.2 Market Estimation Caveats and Base Year
    1.3 Classification of Chimeric Antigen Receptor T Cell Therapy by Type
        1.3.1 Overview: Global Chimeric Antigen Receptor T Cell Therapy Market Size by Type: 2018 Versus 2022 Versus 2029
        1.3.2 Global Chimeric Antigen Receptor T Cell Therapy Consumption Value Market Share by Type in 2022
        1.3.3 Allogeneic
        1.3.4 Autologous
    1.4 Global Chimeric Antigen Receptor T Cell Therapy Market by Application
        1.4.1 Overview: Global Chimeric Antigen Receptor T Cell Therapy Market Size by Application: 2018 Versus 2022 Versus 2029
        1.4.2 Hospitals
        1.4.3 Universities and Colleges
        1.4.4 Others
    1.5 Global Chimeric Antigen Receptor T Cell Therapy Market Size & Forecast
    1.6 Global Chimeric Antigen Receptor T Cell Therapy Market Size and Forecast by Region
        1.6.1 Global Chimeric Antigen Receptor T Cell Therapy Market Size by Region: 2018 VS 2022 VS 2029
        1.6.2 Global Chimeric Antigen Receptor T Cell Therapy Market Size by Region, (2018-2029)
        1.6.3 North America Chimeric Antigen Receptor T Cell Therapy Market Size and Prospect (2018-2029)
        1.6.4 Europe Chimeric Antigen Receptor T Cell Therapy Market Size and Prospect (2018-2029)
        1.6.5 Asia-Pacific Chimeric Antigen Receptor T Cell Therapy Market Size and Prospect (2018-2029)
        1.6.6 South America Chimeric Antigen Receptor T Cell Therapy Market Size and Prospect (2018-2029)
        1.6.7 Middle East and Africa Chimeric Antigen Receptor T Cell Therapy Market Size and Prospect (2018-2029)

2 Company Profiles
    2.1 Amgen
        2.1.1 Amgen Details
        2.1.2 Amgen Major Business
        2.1.3 Amgen Chimeric Antigen Receptor T Cell Therapy Product and Solutions
        2.1.4 Amgen Chimeric Antigen Receptor T Cell Therapy Revenue, Gross Margin and Market Share (2018-2023)
        2.1.5 Amgen Recent Developments and Future Plans
    2.2 Bellicum Pharmaceuticals
        2.2.1 Bellicum Pharmaceuticals Details
        2.2.2 Bellicum Pharmaceuticals Major Business
        2.2.3 Bellicum Pharmaceuticals Chimeric Antigen Receptor T Cell Therapy Product and Solutions
        2.2.4 Bellicum Pharmaceuticals Chimeric Antigen Receptor T Cell Therapy Revenue, Gross Margin and Market Share (2018-2023)
        2.2.5 Bellicum Pharmaceuticals Recent Developments and Future Plans
    2.3 Bluebird Bio
        2.3.1 Bluebird Bio Details
        2.3.2 Bluebird Bio Major Business
        2.3.3 Bluebird Bio Chimeric Antigen Receptor T Cell Therapy Product and Solutions
        2.3.4 Bluebird Bio Chimeric Antigen Receptor T Cell Therapy Revenue, Gross Margin and Market Share (2018-2023)
        2.3.5 Bluebird Bio Recent Developments and Future Plans
    2.4 Caribou Biosciences
        2.4.1 Caribou Biosciences Details
        2.4.2 Caribou Biosciences Major Business
        2.4.3 Caribou Biosciences Chimeric Antigen Receptor T Cell Therapy Product and Solutions
        2.4.4 Caribou Biosciences Chimeric Antigen Receptor T Cell Therapy Revenue, Gross Margin and Market Share (2018-2023)
        2.4.5 Caribou Biosciences Recent Developments and Future Plans
    2.5 Celgene Corporation
        2.5.1 Celgene Corporation Details
        2.5.2 Celgene Corporation Major Business
        2.5.3 Celgene Corporation Chimeric Antigen Receptor T Cell Therapy Product and Solutions
        2.5.4 Celgene Corporation Chimeric Antigen Receptor T Cell Therapy Revenue, Gross Margin and Market Share (2018-2023)
        2.5.5 Celgene Corporation Recent Developments and Future Plans
    2.6 Cellectis
        2.6.1 Cellectis Details
        2.6.2 Cellectis Major Business
        2.6.3 Cellectis Chimeric Antigen Receptor T Cell Therapy Product and Solutions
        2.6.4 Cellectis Chimeric Antigen Receptor T Cell Therapy Revenue, Gross Margin and Market Share (2018-2023)
        2.6.5 Cellectis Recent Developments and Future Plans
    2.7 Celyad Oncology
        2.7.1 Celyad Oncology Details
        2.7.2 Celyad Oncology Major Business
        2.7.3 Celyad Oncology Chimeric Antigen Receptor T Cell Therapy Product and Solutions
        2.7.4 Celyad Oncology Chimeric Antigen Receptor T Cell Therapy Revenue, Gross Margin and Market Share (2018-2023)
        2.7.5 Celyad Oncology Recent Developments and Future Plans
    2.8 Gilead Sciences
        2.8.1 Gilead Sciences Details
        2.8.2 Gilead Sciences Major Business
        2.8.3 Gilead Sciences Chimeric Antigen Receptor T Cell Therapy Product and Solutions
        2.8.4 Gilead Sciences Chimeric Antigen Receptor T Cell Therapy Revenue, Gross Margin and Market Share (2018-2023)
        2.8.5 Gilead Sciences Recent Developments and Future Plans
    2.9 Intellia Therapeutics
        2.9.1 Intellia Therapeutics Details
        2.9.2 Intellia Therapeutics Major Business
        2.9.3 Intellia Therapeutics Chimeric Antigen Receptor T Cell Therapy Product and Solutions
        2.9.4 Intellia Therapeutics Chimeric Antigen Receptor T Cell Therapy Revenue, Gross Margin and Market Share (2018-2023)
        2.9.5 Intellia Therapeutics Recent Developments and Future Plans
    2.10 Johnson & Johnson
        2.10.1 Johnson & Johnson Details
        2.10.2 Johnson & Johnson Major Business
        2.10.3 Johnson & Johnson Chimeric Antigen Receptor T Cell Therapy Product and Solutions
        2.10.4 Johnson & Johnson Chimeric Antigen Receptor T Cell Therapy Revenue, Gross Margin and Market Share (2018-2023)
        2.10.5 Johnson & Johnson Recent Developments and Future Plans
    2.11 Legend Biotech
        2.11.1 Legend Biotech Details
        2.11.2 Legend Biotech Major Business
        2.11.3 Legend Biotech Chimeric Antigen Receptor T Cell Therapy Product and Solutions
        2.11.4 Legend Biotech Chimeric Antigen Receptor T Cell Therapy Revenue, Gross Margin and Market Share (2018-2023)
        2.11.5 Legend Biotech Recent Developments and Future Plans
    2.12 Merck
        2.12.1 Merck Details
        2.12.2 Merck Major Business
        2.12.3 Merck Chimeric Antigen Receptor T Cell Therapy Product and Solutions
        2.12.4 Merck Chimeric Antigen Receptor T Cell Therapy Revenue, Gross Margin and Market Share (2018-2023)
        2.12.5 Merck Recent Developments and Future Plans
    2.13 Noile-Immune Biotech
        2.13.1 Noile-Immune Biotech Details
        2.13.2 Noile-Immune Biotech Major Business
        2.13.3 Noile-Immune Biotech Chimeric Antigen Receptor T Cell Therapy Product and Solutions
        2.13.4 Noile-Immune Biotech Chimeric Antigen Receptor T Cell Therapy Revenue, Gross Margin and Market Share (2018-2023)
        2.13.5 Noile-Immune Biotech Recent Developments and Future Plans
    2.14 Novartis
        2.14.1 Novartis Details
        2.14.2 Novartis Major Business
        2.14.3 Novartis Chimeric Antigen Receptor T Cell Therapy Product and Solutions
        2.14.4 Novartis Chimeric Antigen Receptor T Cell Therapy Revenue, Gross Margin and Market Share (2018-2023)
        2.14.5 Novartis Recent Developments and Future Plans
    2.15 Pfizer
        2.15.1 Pfizer Details
        2.15.2 Pfizer Major Business
        2.15.3 Pfizer Chimeric Antigen Receptor T Cell Therapy Product and Solutions
        2.15.4 Pfizer Chimeric Antigen Receptor T Cell Therapy Revenue, Gross Margin and Market Share (2018-2023)
        2.15.5 Pfizer Recent Developments and Future Plans
    2.16 Sangamo Therapeutics
        2.16.1 Sangamo Therapeutics Details
        2.16.2 Sangamo Therapeutics Major Business
        2.16.3 Sangamo Therapeutics Chimeric Antigen Receptor T Cell Therapy Product and Solutions
        2.16.4 Sangamo Therapeutics Chimeric Antigen Receptor T Cell Therapy Revenue, Gross Margin and Market Share (2018-2023)
        2.16.5 Sangamo Therapeutics Recent Developments and Future Plans
    2.17 Servier Laboratories
        2.17.1 Servier Laboratories Details
        2.17.2 Servier Laboratories Major Business
        2.17.3 Servier Laboratories Chimeric Antigen Receptor T Cell Therapy Product and Solutions
        2.17.4 Servier Laboratories Chimeric Antigen Receptor T Cell Therapy Revenue, Gross Margin and Market Share (2018-2023)
        2.17.5 Servier Laboratories Recent Developments and Future Plans

3 Market Competition, by Players
    3.1 Global Chimeric Antigen Receptor T Cell Therapy Revenue and Share by Players (2018-2023)
    3.2 Market Share Analysis (2022)
        3.2.1 Market Share of Chimeric Antigen Receptor T Cell Therapy by Company Revenue
        3.2.2 Top 3 Chimeric Antigen Receptor T Cell Therapy Players Market Share in 2022
        3.2.3 Top 6 Chimeric Antigen Receptor T Cell Therapy Players Market Share in 2022
    3.3 Chimeric Antigen Receptor T Cell Therapy Market: Overall Company Footprint Analysis
        3.3.1 Chimeric Antigen Receptor T Cell Therapy Market: Region Footprint
        3.3.2 Chimeric Antigen Receptor T Cell Therapy Market: Company Product Type Footprint
        3.3.3 Chimeric Antigen Receptor T Cell Therapy Market: Company Product Application Footprint
    3.4 New Market Entrants and Barriers to Market Entry
    3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type
    4.1 Global Chimeric Antigen Receptor T Cell Therapy Consumption Value and Market Share by Type (2018-2023)
    4.2 Global Chimeric Antigen Receptor T Cell Therapy Market Forecast by Type (2024-2029)

5 Market Size Segment by Application
    5.1 Global Chimeric Antigen Receptor T Cell Therapy Consumption Value Market Share by Application (2018-2023)
    5.2 Global Chimeric Antigen Receptor T Cell Therapy Market Forecast by Application (2024-2029)

6 North America
    6.1 North America Chimeric Antigen Receptor T Cell Therapy Consumption Value by Type (2018-2029)
    6.2 North America Chimeric Antigen Receptor T Cell Therapy Consumption Value by Application (2018-2029)
    6.3 North America Chimeric Antigen Receptor T Cell Therapy Market Size by Country
        6.3.1 North America Chimeric Antigen Receptor T Cell Therapy Consumption Value by Country (2018-2029)
        6.3.2 United States Chimeric Antigen Receptor T Cell Therapy Market Size and Forecast (2018-2029)
        6.3.3 Canada Chimeric Antigen Receptor T Cell Therapy Market Size and Forecast (2018-2029)
        6.3.4 Mexico Chimeric Antigen Receptor T Cell Therapy Market Size and Forecast (2018-2029)

7 Europe
    7.1 Europe Chimeric Antigen Receptor T Cell Therapy Consumption Value by Type (2018-2029)
    7.2 Europe Chimeric Antigen Receptor T Cell Therapy Consumption Value by Application (2018-2029)
    7.3 Europe Chimeric Antigen Receptor T Cell Therapy Market Size by Country
        7.3.1 Europe Chimeric Antigen Receptor T Cell Therapy Consumption Value by Country (2018-2029)
        7.3.2 Germany Chimeric Antigen Receptor T Cell Therapy Market Size and Forecast (2018-2029)
        7.3.3 France Chimeric Antigen Receptor T Cell Therapy Market Size and Forecast (2018-2029)
        7.3.4 United Kingdom Chimeric Antigen Receptor T Cell Therapy Market Size and Forecast (2018-2029)
        7.3.5 Russia Chimeric Antigen Receptor T Cell Therapy Market Size and Forecast (2018-2029)
        7.3.6 Italy Chimeric Antigen Receptor T Cell Therapy Market Size and Forecast (2018-2029)

8 Asia-Pacific
    8.1 Asia-Pacific Chimeric Antigen Receptor T Cell Therapy Consumption Value by Type (2018-2029)
    8.2 Asia-Pacific Chimeric Antigen Receptor T Cell Therapy Consumption Value by Application (2018-2029)
    8.3 Asia-Pacific Chimeric Antigen Receptor T Cell Therapy Market Size by Region
        8.3.1 Asia-Pacific Chimeric Antigen Receptor T Cell Therapy Consumption Value by Region (2018-2029)
        8.3.2 China Chimeric Antigen Receptor T Cell Therapy Market Size and Forecast (2018-2029)
        8.3.3 Japan Chimeric Antigen Receptor T Cell Therapy Market Size and Forecast (2018-2029)
        8.3.4 South Korea Chimeric Antigen Receptor T Cell Therapy Market Size and Forecast (2018-2029)
        8.3.5 India Chimeric Antigen Receptor T Cell Therapy Market Size and Forecast (2018-2029)
        8.3.6 Southeast Asia Chimeric Antigen Receptor T Cell Therapy Market Size and Forecast (2018-2029)
        8.3.7 Australia Chimeric Antigen Receptor T Cell Therapy Market Size and Forecast (2018-2029)

9 South America
    9.1 South America Chimeric Antigen Receptor T Cell Therapy Consumption Value by Type (2018-2029)
    9.2 South America Chimeric Antigen Receptor T Cell Therapy Consumption Value by Application (2018-2029)
    9.3 South America Chimeric Antigen Receptor T Cell Therapy Market Size by Country
        9.3.1 South America Chimeric Antigen Receptor T Cell Therapy Consumption Value by Country (2018-2029)
        9.3.2 Brazil Chimeric Antigen Receptor T Cell Therapy Market Size and Forecast (2018-2029)
        9.3.3 Argentina Chimeric Antigen Receptor T Cell Therapy Market Size and Forecast (2018-2029)

10 Middle East & Africa
    10.1 Middle East & Africa Chimeric Antigen Receptor T Cell Therapy Consumption Value by Type (2018-2029)
    10.2 Middle East & Africa Chimeric Antigen Receptor T Cell Therapy Consumption Value by Application (2018-2029)
    10.3 Middle East & Africa Chimeric Antigen Receptor T Cell Therapy Market Size by Country
        10.3.1 Middle East & Africa Chimeric Antigen Receptor T Cell Therapy Consumption Value by Country (2018-2029)
        10.3.2 Turkey Chimeric Antigen Receptor T Cell Therapy Market Size and Forecast (2018-2029)
        10.3.3 Saudi Arabia Chimeric Antigen Receptor T Cell Therapy Market Size and Forecast (2018-2029)
        10.3.4 UAE Chimeric Antigen Receptor T Cell Therapy Market Size and Forecast (2018-2029)

11 Market Dynamics
    11.1 Chimeric Antigen Receptor T Cell Therapy Market Drivers
    11.2 Chimeric Antigen Receptor T Cell Therapy Market Restraints
    11.3 Chimeric Antigen Receptor T Cell Therapy Trends Analysis
    11.4 Porters Five Forces Analysis
        11.4.1 Threat of New Entrants
        11.4.2 Bargaining Power of Suppliers
        11.4.3 Bargaining Power of Buyers
        11.4.4 Threat of Substitutes
        11.4.5 Competitive Rivalry
    11.5 Influence of COVID-19 and Russia-Ukraine War
        11.5.1 Influence of COVID-19
        11.5.2 Influence of Russia-Ukraine War

12 Industry Chain Analysis
    12.1 Chimeric Antigen Receptor T Cell Therapy Industry Chain
    12.2 Chimeric Antigen Receptor T Cell Therapy Upstream Analysis
    12.3 Chimeric Antigen Receptor T Cell Therapy Midstream Analysis
    12.4 Chimeric Antigen Receptor T Cell Therapy Downstream Analysis

13 Research Findings and Conclusion

14 Appendix
    14.1 Methodology
    14.2 Research Process and Data Source
    14.3 Disclaimer

Table of Figures

List of Tables
    Table 1. Global Chimeric Antigen Receptor T Cell Therapy Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
    Table 2. Global Chimeric Antigen Receptor T Cell Therapy Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
    Table 3. Global Chimeric Antigen Receptor T Cell Therapy Consumption Value by Region (2018-2023) & (USD Million)
    Table 4. Global Chimeric Antigen Receptor T Cell Therapy Consumption Value by Region (2024-2029) & (USD Million)
    Table 5. Amgen Company Information, Head Office, and Major Competitors
    Table 6. Amgen Major Business
    Table 7. Amgen Chimeric Antigen Receptor T Cell Therapy Product and Solutions
    Table 8. Amgen Chimeric Antigen Receptor T Cell Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 9. Amgen Recent Developments and Future Plans
    Table 10. Bellicum Pharmaceuticals Company Information, Head Office, and Major Competitors
    Table 11. Bellicum Pharmaceuticals Major Business
    Table 12. Bellicum Pharmaceuticals Chimeric Antigen Receptor T Cell Therapy Product and Solutions
    Table 13. Bellicum Pharmaceuticals Chimeric Antigen Receptor T Cell Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 14. Bellicum Pharmaceuticals Recent Developments and Future Plans
    Table 15. Bluebird Bio Company Information, Head Office, and Major Competitors
    Table 16. Bluebird Bio Major Business
    Table 17. Bluebird Bio Chimeric Antigen Receptor T Cell Therapy Product and Solutions
    Table 18. Bluebird Bio Chimeric Antigen Receptor T Cell Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 19. Bluebird Bio Recent Developments and Future Plans
    Table 20. Caribou Biosciences Company Information, Head Office, and Major Competitors
    Table 21. Caribou Biosciences Major Business
    Table 22. Caribou Biosciences Chimeric Antigen Receptor T Cell Therapy Product and Solutions
    Table 23. Caribou Biosciences Chimeric Antigen Receptor T Cell Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 24. Caribou Biosciences Recent Developments and Future Plans
    Table 25. Celgene Corporation Company Information, Head Office, and Major Competitors
    Table 26. Celgene Corporation Major Business
    Table 27. Celgene Corporation Chimeric Antigen Receptor T Cell Therapy Product and Solutions
    Table 28. Celgene Corporation Chimeric Antigen Receptor T Cell Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 29. Celgene Corporation Recent Developments and Future Plans
    Table 30. Cellectis Company Information, Head Office, and Major Competitors
    Table 31. Cellectis Major Business
    Table 32. Cellectis Chimeric Antigen Receptor T Cell Therapy Product and Solutions
    Table 33. Cellectis Chimeric Antigen Receptor T Cell Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 34. Cellectis Recent Developments and Future Plans
    Table 35. Celyad Oncology Company Information, Head Office, and Major Competitors
    Table 36. Celyad Oncology Major Business
    Table 37. Celyad Oncology Chimeric Antigen Receptor T Cell Therapy Product and Solutions
    Table 38. Celyad Oncology Chimeric Antigen Receptor T Cell Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 39. Celyad Oncology Recent Developments and Future Plans
    Table 40. Gilead Sciences Company Information, Head Office, and Major Competitors
    Table 41. Gilead Sciences Major Business
    Table 42. Gilead Sciences Chimeric Antigen Receptor T Cell Therapy Product and Solutions
    Table 43. Gilead Sciences Chimeric Antigen Receptor T Cell Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 44. Gilead Sciences Recent Developments and Future Plans
    Table 45. Intellia Therapeutics Company Information, Head Office, and Major Competitors
    Table 46. Intellia Therapeutics Major Business
    Table 47. Intellia Therapeutics Chimeric Antigen Receptor T Cell Therapy Product and Solutions
    Table 48. Intellia Therapeutics Chimeric Antigen Receptor T Cell Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 49. Intellia Therapeutics Recent Developments and Future Plans
    Table 50. Johnson & Johnson Company Information, Head Office, and Major Competitors
    Table 51. Johnson & Johnson Major Business
    Table 52. Johnson & Johnson Chimeric Antigen Receptor T Cell Therapy Product and Solutions
    Table 53. Johnson & Johnson Chimeric Antigen Receptor T Cell Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 54. Johnson & Johnson Recent Developments and Future Plans
    Table 55. Legend Biotech Company Information, Head Office, and Major Competitors
    Table 56. Legend Biotech Major Business
    Table 57. Legend Biotech Chimeric Antigen Receptor T Cell Therapy Product and Solutions
    Table 58. Legend Biotech Chimeric Antigen Receptor T Cell Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 59. Legend Biotech Recent Developments and Future Plans
    Table 60. Merck Company Information, Head Office, and Major Competitors
    Table 61. Merck Major Business
    Table 62. Merck Chimeric Antigen Receptor T Cell Therapy Product and Solutions
    Table 63. Merck Chimeric Antigen Receptor T Cell Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 64. Merck Recent Developments and Future Plans
    Table 65. Noile-Immune Biotech Company Information, Head Office, and Major Competitors
    Table 66. Noile-Immune Biotech Major Business
    Table 67. Noile-Immune Biotech Chimeric Antigen Receptor T Cell Therapy Product and Solutions
    Table 68. Noile-Immune Biotech Chimeric Antigen Receptor T Cell Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 69. Noile-Immune Biotech Recent Developments and Future Plans
    Table 70. Novartis Company Information, Head Office, and Major Competitors
    Table 71. Novartis Major Business
    Table 72. Novartis Chimeric Antigen Receptor T Cell Therapy Product and Solutions
    Table 73. Novartis Chimeric Antigen Receptor T Cell Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 74. Novartis Recent Developments and Future Plans
    Table 75. Pfizer Company Information, Head Office, and Major Competitors
    Table 76. Pfizer Major Business
    Table 77. Pfizer Chimeric Antigen Receptor T Cell Therapy Product and Solutions
    Table 78. Pfizer Chimeric Antigen Receptor T Cell Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 79. Pfizer Recent Developments and Future Plans
    Table 80. Sangamo Therapeutics Company Information, Head Office, and Major Competitors
    Table 81. Sangamo Therapeutics Major Business
    Table 82. Sangamo Therapeutics Chimeric Antigen Receptor T Cell Therapy Product and Solutions
    Table 83. Sangamo Therapeutics Chimeric Antigen Receptor T Cell Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 84. Sangamo Therapeutics Recent Developments and Future Plans
    Table 85. Servier Laboratories Company Information, Head Office, and Major Competitors
    Table 86. Servier Laboratories Major Business
    Table 87. Servier Laboratories Chimeric Antigen Receptor T Cell Therapy Product and Solutions
    Table 88. Servier Laboratories Chimeric Antigen Receptor T Cell Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 89. Servier Laboratories Recent Developments and Future Plans
    Table 90. Global Chimeric Antigen Receptor T Cell Therapy Revenue (USD Million) by Players (2018-2023)
    Table 91. Global Chimeric Antigen Receptor T Cell Therapy Revenue Share by Players (2018-2023)
    Table 92. Breakdown of Chimeric Antigen Receptor T Cell Therapy by Company Type (Tier 1, Tier 2, and Tier 3)
    Table 93. Market Position of Players in Chimeric Antigen Receptor T Cell Therapy, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2022
    Table 94. Head Office of Key Chimeric Antigen Receptor T Cell Therapy Players
    Table 95. Chimeric Antigen Receptor T Cell Therapy Market: Company Product Type Footprint
    Table 96. Chimeric Antigen Receptor T Cell Therapy Market: Company Product Application Footprint
    Table 97. Chimeric Antigen Receptor T Cell Therapy New Market Entrants and Barriers to Market Entry
    Table 98. Chimeric Antigen Receptor T Cell Therapy Mergers, Acquisition, Agreements, and Collaborations
    Table 99. Global Chimeric Antigen Receptor T Cell Therapy Consumption Value (USD Million) by Type (2018-2023)
    Table 100. Global Chimeric Antigen Receptor T Cell Therapy Consumption Value Share by Type (2018-2023)
    Table 101. Global Chimeric Antigen Receptor T Cell Therapy Consumption Value Forecast by Type (2024-2029)
    Table 102. Global Chimeric Antigen Receptor T Cell Therapy Consumption Value by Application (2018-2023)
    Table 103. Global Chimeric Antigen Receptor T Cell Therapy Consumption Value Forecast by Application (2024-2029)
    Table 104. North America Chimeric Antigen Receptor T Cell Therapy Consumption Value by Type (2018-2023) & (USD Million)
    Table 105. North America Chimeric Antigen Receptor T Cell Therapy Consumption Value by Type (2024-2029) & (USD Million)
    Table 106. North America Chimeric Antigen Receptor T Cell Therapy Consumption Value by Application (2018-2023) & (USD Million)
    Table 107. North America Chimeric Antigen Receptor T Cell Therapy Consumption Value by Application (2024-2029) & (USD Million)
    Table 108. North America Chimeric Antigen Receptor T Cell Therapy Consumption Value by Country (2018-2023) & (USD Million)
    Table 109. North America Chimeric Antigen Receptor T Cell Therapy Consumption Value by Country (2024-2029) & (USD Million)
    Table 110. Europe Chimeric Antigen Receptor T Cell Therapy Consumption Value by Type (2018-2023) & (USD Million)
    Table 111. Europe Chimeric Antigen Receptor T Cell Therapy Consumption Value by Type (2024-2029) & (USD Million)
    Table 112. Europe Chimeric Antigen Receptor T Cell Therapy Consumption Value by Application (2018-2023) & (USD Million)
    Table 113. Europe Chimeric Antigen Receptor T Cell Therapy Consumption Value by Application (2024-2029) & (USD Million)
    Table 114. Europe Chimeric Antigen Receptor T Cell Therapy Consumption Value by Country (2018-2023) & (USD Million)
    Table 115. Europe Chimeric Antigen Receptor T Cell Therapy Consumption Value by Country (2024-2029) & (USD Million)
    Table 116. Asia-Pacific Chimeric Antigen Receptor T Cell Therapy Consumption Value by Type (2018-2023) & (USD Million)
    Table 117. Asia-Pacific Chimeric Antigen Receptor T Cell Therapy Consumption Value by Type (2024-2029) & (USD Million)
    Table 118. Asia-Pacific Chimeric Antigen Receptor T Cell Therapy Consumption Value by Application (2018-2023) & (USD Million)
    Table 119. Asia-Pacific Chimeric Antigen Receptor T Cell Therapy Consumption Value by Application (2024-2029) & (USD Million)
    Table 120. Asia-Pacific Chimeric Antigen Receptor T Cell Therapy Consumption Value by Region (2018-2023) & (USD Million)
    Table 121. Asia-Pacific Chimeric Antigen Receptor T Cell Therapy Consumption Value by Region (2024-2029) & (USD Million)
    Table 122. South America Chimeric Antigen Receptor T Cell Therapy Consumption Value by Type (2018-2023) & (USD Million)
    Table 123. South America Chimeric Antigen Receptor T Cell Therapy Consumption Value by Type (2024-2029) & (USD Million)
    Table 124. South America Chimeric Antigen Receptor T Cell Therapy Consumption Value by Application (2018-2023) & (USD Million)
    Table 125. South America Chimeric Antigen Receptor T Cell Therapy Consumption Value by Application (2024-2029) & (USD Million)
    Table 126. South America Chimeric Antigen Receptor T Cell Therapy Consumption Value by Country (2018-2023) & (USD Million)
    Table 127. South America Chimeric Antigen Receptor T Cell Therapy Consumption Value by Country (2024-2029) & (USD Million)
    Table 128. Middle East & Africa Chimeric Antigen Receptor T Cell Therapy Consumption Value by Type (2018-2023) & (USD Million)
    Table 129. Middle East & Africa Chimeric Antigen Receptor T Cell Therapy Consumption Value by Type (2024-2029) & (USD Million)
    Table 130. Middle East & Africa Chimeric Antigen Receptor T Cell Therapy Consumption Value by Application (2018-2023) & (USD Million)
    Table 131. Middle East & Africa Chimeric Antigen Receptor T Cell Therapy Consumption Value by Application (2024-2029) & (USD Million)
    Table 132. Middle East & Africa Chimeric Antigen Receptor T Cell Therapy Consumption Value by Country (2018-2023) & (USD Million)
    Table 133. Middle East & Africa Chimeric Antigen Receptor T Cell Therapy Consumption Value by Country (2024-2029) & (USD Million)
    Table 134. Chimeric Antigen Receptor T Cell Therapy Raw Material
    Table 135. Key Suppliers of Chimeric Antigen Receptor T Cell Therapy Raw Materials
List of Figures
    Figure 1. Chimeric Antigen Receptor T Cell Therapy Picture
    Figure 2. Global Chimeric Antigen Receptor T Cell Therapy Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
    Figure 3. Global Chimeric Antigen Receptor T Cell Therapy Consumption Value Market Share by Type in 2022
    Figure 4. Allogeneic
    Figure 5. Autologous
    Figure 6. Global Chimeric Antigen Receptor T Cell Therapy Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
    Figure 7. Chimeric Antigen Receptor T Cell Therapy Consumption Value Market Share by Application in 2022
    Figure 8. Hospitals Picture
    Figure 9. Universities and Colleges Picture
    Figure 10. Others Picture
    Figure 11. Global Chimeric Antigen Receptor T Cell Therapy Consumption Value, (USD Million): 2018 & 2022 & 2029
    Figure 12. Global Chimeric Antigen Receptor T Cell Therapy Consumption Value and Forecast (2018-2029) & (USD Million)
    Figure 13. Global Market Chimeric Antigen Receptor T Cell Therapy Consumption Value (USD Million) Comparison by Region (2018 & 2022 & 2029)
    Figure 14. Global Chimeric Antigen Receptor T Cell Therapy Consumption Value Market Share by Region (2018-2029)
    Figure 15. Global Chimeric Antigen Receptor T Cell Therapy Consumption Value Market Share by Region in 2022
    Figure 16. North America Chimeric Antigen Receptor T Cell Therapy Consumption Value (2018-2029) & (USD Million)
    Figure 17. Europe Chimeric Antigen Receptor T Cell Therapy Consumption Value (2018-2029) & (USD Million)
    Figure 18. Asia-Pacific Chimeric Antigen Receptor T Cell Therapy Consumption Value (2018-2029) & (USD Million)
    Figure 19. South America Chimeric Antigen Receptor T Cell Therapy Consumption Value (2018-2029) & (USD Million)
    Figure 20. Middle East and Africa Chimeric Antigen Receptor T Cell Therapy Consumption Value (2018-2029) & (USD Million)
    Figure 21. Global Chimeric Antigen Receptor T Cell Therapy Revenue Share by Players in 2022
    Figure 22. Chimeric Antigen Receptor T Cell Therapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2022
    Figure 23. Global Top 3 Players Chimeric Antigen Receptor T Cell Therapy Market Share in 2022
    Figure 24. Global Top 6 Players Chimeric Antigen Receptor T Cell Therapy Market Share in 2022
    Figure 25. Global Chimeric Antigen Receptor T Cell Therapy Consumption Value Share by Type (2018-2023)
    Figure 26. Global Chimeric Antigen Receptor T Cell Therapy Market Share Forecast by Type (2024-2029)
    Figure 27. Global Chimeric Antigen Receptor T Cell Therapy Consumption Value Share by Application (2018-2023)
    Figure 28. Global Chimeric Antigen Receptor T Cell Therapy Market Share Forecast by Application (2024-2029)
    Figure 29. North America Chimeric Antigen Receptor T Cell Therapy Consumption Value Market Share by Type (2018-2029)
    Figure 30. North America Chimeric Antigen Receptor T Cell Therapy Consumption Value Market Share by Application (2018-2029)
    Figure 31. North America Chimeric Antigen Receptor T Cell Therapy Consumption Value Market Share by Country (2018-2029)
    Figure 32. United States Chimeric Antigen Receptor T Cell Therapy Consumption Value (2018-2029) & (USD Million)
    Figure 33. Canada Chimeric Antigen Receptor T Cell Therapy Consumption Value (2018-2029) & (USD Million)
    Figure 34. Mexico Chimeric Antigen Receptor T Cell Therapy Consumption Value (2018-2029) & (USD Million)
    Figure 35. Europe Chimeric Antigen Receptor T Cell Therapy Consumption Value Market Share by Type (2018-2029)
    Figure 36. Europe Chimeric Antigen Receptor T Cell Therapy Consumption Value Market Share by Application (2018-2029)
    Figure 37. Europe Chimeric Antigen Receptor T Cell Therapy Consumption Value Market Share by Country (2018-2029)
    Figure 38. Germany Chimeric Antigen Receptor T Cell Therapy Consumption Value (2018-2029) & (USD Million)
    Figure 39. France Chimeric Antigen Receptor T Cell Therapy Consumption Value (2018-2029) & (USD Million)
    Figure 40. United Kingdom Chimeric Antigen Receptor T Cell Therapy Consumption Value (2018-2029) & (USD Million)
    Figure 41. Russia Chimeric Antigen Receptor T Cell Therapy Consumption Value (2018-2029) & (USD Million)
    Figure 42. Italy Chimeric Antigen Receptor T Cell Therapy Consumption Value (2018-2029) & (USD Million)
    Figure 43. Asia-Pacific Chimeric Antigen Receptor T Cell Therapy Consumption Value Market Share by Type (2018-2029)
    Figure 44. Asia-Pacific Chimeric Antigen Receptor T Cell Therapy Consumption Value Market Share by Application (2018-2029)
    Figure 45. Asia-Pacific Chimeric Antigen Receptor T Cell Therapy Consumption Value Market Share by Region (2018-2029)
    Figure 46. China Chimeric Antigen Receptor T Cell Therapy Consumption Value (2018-2029) & (USD Million)
    Figure 47. Japan Chimeric Antigen Receptor T Cell Therapy Consumption Value (2018-2029) & (USD Million)
    Figure 48. South Korea Chimeric Antigen Receptor T Cell Therapy Consumption Value (2018-2029) & (USD Million)
    Figure 49. India Chimeric Antigen Receptor T Cell Therapy Consumption Value (2018-2029) & (USD Million)
    Figure 50. Southeast Asia Chimeric Antigen Receptor T Cell Therapy Consumption Value (2018-2029) & (USD Million)
    Figure 51. Australia Chimeric Antigen Receptor T Cell Therapy Consumption Value (2018-2029) & (USD Million)
    Figure 52. South America Chimeric Antigen Receptor T Cell Therapy Consumption Value Market Share by Type (2018-2029)
    Figure 53. South America Chimeric Antigen Receptor T Cell Therapy Consumption Value Market Share by Application (2018-2029)
    Figure 54. South America Chimeric Antigen Receptor T Cell Therapy Consumption Value Market Share by Country (2018-2029)
    Figure 55. Brazil Chimeric Antigen Receptor T Cell Therapy Consumption Value (2018-2029) & (USD Million)
    Figure 56. Argentina Chimeric Antigen Receptor T Cell Therapy Consumption Value (2018-2029) & (USD Million)
    Figure 57. Middle East and Africa Chimeric Antigen Receptor T Cell Therapy Consumption Value Market Share by Type (2018-2029)
    Figure 58. Middle East and Africa Chimeric Antigen Receptor T Cell Therapy Consumption Value Market Share by Application (2018-2029)
    Figure 59. Middle East and Africa Chimeric Antigen Receptor T Cell Therapy Consumption Value Market Share by Country (2018-2029)
    Figure 60. Turkey Chimeric Antigen Receptor T Cell Therapy Consumption Value (2018-2029) & (USD Million)
    Figure 61. Saudi Arabia Chimeric Antigen Receptor T Cell Therapy Consumption Value (2018-2029) & (USD Million)
    Figure 62. UAE Chimeric Antigen Receptor T Cell Therapy Consumption Value (2018-2029) & (USD Million)
    Figure 63. Chimeric Antigen Receptor T Cell Therapy Market Drivers
    Figure 64. Chimeric Antigen Receptor T Cell Therapy Market Restraints
    Figure 65. Chimeric Antigen Receptor T Cell Therapy Market Trends
    Figure 66. Porters Five Forces Analysis
    Figure 67. Manufacturing Cost Structure Analysis of Chimeric Antigen Receptor T Cell Therapy in 2022
    Figure 68. Manufacturing Process Analysis of Chimeric Antigen Receptor T Cell Therapy
    Figure 69. Chimeric Antigen Receptor T Cell Therapy Industrial Chain
    Figure 70. Methodology
    Figure 71. Research Process and Data Source

Research Methodology

Client Requirements

Review and analyze client requirements

Discussion of all the project requirements and queries

Flexibility Check

Project Feasibility Analysis

Finalizing tentative research programme

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

Determination of key drivers, restraints, challenge, and opportunity

Identifies market needs and trends

Market Size Estimation & Forecast

Estimation of historical data based on secondary and primary data

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

Consideration of geography, region-specific product/service demand for region segments

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

Data Source

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

Collection of data

Cumulating and collating the essential qualitative and quantitative data

Generation of report in client requested format by research analysts

Reviews by expert analysts

Final quality check

Clarifying queries

Receiving feedback

Ensuring satisfaction

01 Identification of data

This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
02 Evaluation of Market Dynamic

This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
03 Collection of Data

This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
04 Collaboration of Data

This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis

This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

Related Reports

Global Chimeric Antigen Receptor T Cell Therapy Supply, Demand and Key Producers, 2023-2029

Global Chimeric Antigen Receptor T Cell Therapy Supply, Demand and Key Producers, 2023-2029

date 24 Feb 2023

date Medical Care

The global Chimeric Antigen Receptor T Cell Therapy market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).

Global Chimeric Antigen Receptor T Cell Therapy Market 2024 by Company, Regions, Type and Application, Forecast to 2030

Global Chimeric Antigen Receptor T Cell Therapy Market 2024 by Company, Regions, Type and Application, Forecast to 2030

date 02 Jan 2024

date Medical Care

According to our (Global Info Research) latest study, the global Chimeric Antigen Receptor T Cell Therapy market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period.

Product Tags

Chimeric Antigen Receptor T Cell Therapy

Organ Rejection Prophylaxis Treatment

Biologics Analytical Services

Purchase Options

Single User License

USD3480.00

Multi User License

USD5220.00

Corporate Users License

USD6960.00

Add To Cart

Buy Now

Popular Product Keywords

AI
semiconductor
electron
5G
artificial intelligence
Battery
new energy
We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.

Speak to our analyst >>
Our Clients
What We Can Provide?

With better results and higher quality products,Our professional reports can achieve four things:
- Insight into the industry market information
- Analyze market development needs
- Prospects for future development
- Develop industry investment strategy
Digging deeper into global industry information and providing market strategies.

Contact Us >>